HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Eiraku Selected Research

Antirheumatic Agents (DMARD)

1/2022Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.
1/2020Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Eiraku Research Topics

Disease

3Rheumatoid Arthritis
01/2022 - 01/2020
1Rheumatic Diseases (Rheumatism)
01/2021
1Necrosis
01/2020

Drug/Important Bio-Agent (IBA)

2Antirheumatic Agents (DMARD)IBA
01/2022 - 01/2020
2Abatacept (Orencia)FDA Link
01/2021 - 01/2020
1Janus KinasesIBA
01/2022
1Janus Kinase InhibitorsIBA
01/2022
1AntigensIBA
01/2021
1AntibodiesIBA
01/2021
1Tumor Necrosis Factor InhibitorsIBA
01/2020
1Anti-Citrullinated Protein AntibodiesIBA
01/2020

Therapy/Procedure

1Aftercare (After-Treatment)
01/2021